ScholarIQanswers from OpenAlex

III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis

PaperCitations, authors & open-access status

III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis have?

ScholarIQcitation count

III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis has 282 citations in the OpenAlex counts ScholarIQ stores.

When was III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis published?

ScholarIQyear

III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis has 2002 year in the ScholarIQ index.

What is the open-access status of III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis?

ScholarIQoa status

III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis has bronze oa status in the ScholarIQ index.

What is the DOI of III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis?

ScholarIQdoi

The DOI for III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis is on the source record.

What is the PMID of III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis?

ScholarIQpmid

The PMID for III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis is on the source record.

What is the OpenAlex record for III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis?

ScholarIQopenalex

The OpenAlex for III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial